Ursodeoxycholic acid administration did not reduce susceptibility to SARS-CoV-2 infection in children.

Published in: Liver international : official journal of the International Association for the Study of the Liver (2023)

These results indicate that UDCA administration does not reduce susceptibility to SARS-CoV-2 infection in children with liver disease.

Keyphrases